Equillium, Inc. (EQ) stock
EQNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.32−0.10 (-7.04%)
Close on Nov 12, 2026Market cap $83.70MP/E –Yield –
Equillium profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Equillium's profit margin for the twelve months ending Dec 31, 2024 was -19.6%. For fiscal 2024 it was -19.6%, against -37.0% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -19.6% | +17.3 |
| FY2023 | Dec 31, 2023 | -37.0% | +359.2 |
| FY2022 | Dec 31, 2022 | -396.1% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | -131.9% | −106.5 |
| Q3 FY2024 | Sep 30, 2024 | -0.1% | +41.8 |
| Q2 FY2024 | Jun 30, 2024 | 3.4% | +40.0 |
| Q1 FY2024 | Mar 31, 2024 | -25.6% | +18.8 |
| Q4 FY2023 | Dec 31, 2023 | -25.4% | – |
| Q3 FY2023 | Sep 30, 2023 | -41.8% | – |
| Q2 FY2023 | Jun 30, 2023 | -36.6% | – |
| Q1 FY2023 | Mar 31, 2023 | -44.4% | – |
See a number that looks wrong?